254 related articles for article (PubMed ID: 18073300)
1. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity.
Huber AK; Jacobson EM; Jazdzewski K; Concepcion ES; Tomer Y
J Clin Endocrinol Metab; 2008 Mar; 93(3):1077-81. PubMed ID: 18073300
[TBL] [Abstract][Full Text] [Related]
2. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population.
Ban Y; Tozaki T; Taniyama M; Nakano Y; Yoneyama K; Ban Y; Hirano T
Autoimmunity; 2009 Feb; 42(2):126-30. PubMed ID: 19021011
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between rheumatoid arthritis and genetic variants rs10889677, rs11209026 and rs2201841 of IL-23R gene.
Paradowska-Gorycka A; Malinowski D; Haladyj E; Olesinska M; Safranow K; Pawlik A
Med Clin (Barc); 2018 Sep; 151(5):191-195. PubMed ID: 29370888
[TBL] [Abstract][Full Text] [Related]
4.
Zhang M; Liu S; Xu J; Lv S; Fan Y; Zhang Y; Zhang Y; Wu Y; Su Y; Yu H; Song S; He J; Li H
Curr Eye Res; 2020 Jul; 45(7):888-895. PubMed ID: 31869260
[TBL] [Abstract][Full Text] [Related]
5. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
Du J; Wang X; Tan G; Wei W; Zhou F; Liang Z; Li H; Yu H
J Mol Med (Berl); 2021 Oct; 99(10):1487-1495. PubMed ID: 34287665
[TBL] [Abstract][Full Text] [Related]
6. The Role of
Yaylacıoğlu Tuncay F; Serbest Ceylanoğlu K; Güntekin Ergün S; Ergün G; Konuk O
Turk J Ophthalmol; 2024 Apr; 54(2):69-75. PubMed ID: 38645270
[TBL] [Abstract][Full Text] [Related]
7. IL-23R gene polymorphisms in rheumatoid arthritis.
Soysal E; Ulutaş F; Tepeli E; Kaymaz S; Çobankara V
Rheumatol Int; 2022 Mar; 42(3):555-562. PubMed ID: 33978821
[TBL] [Abstract][Full Text] [Related]
8. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Davies TF
Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
[TBL] [Abstract][Full Text] [Related]
9. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.
Khalilzadeh O; Anvari M; Esteghamati A; Mahmoudi M; Tahvildari M; Rashidi A; Khosravi F; Amirzargar A
Clin Exp Ophthalmol; 2009 Aug; 37(6):614-9. PubMed ID: 19702713
[TBL] [Abstract][Full Text] [Related]
10. The VDR gene confers a genetic predisposition to Graves' disease and Graves' ophthalmopathy in the Southwest Chinese Han population.
Zhou F; Liang Z; Wang X; Tan G; Wei W; Zheng G; Ma X; Tian D; Li H; Yu H
Gene; 2021 Aug; 793():145750. PubMed ID: 34077777
[TBL] [Abstract][Full Text] [Related]
11. Investigation of association of the IL-12B and IL-23R genetic variations with psoriatic risk in a South Indian Tamil cohort.
Indhumathi S; Rajappa M; Chandrashekar L; Ananthanarayanan PH; Thappa DM; Negi VS
Hum Immunol; 2016 Jan; 77(1):54-62. PubMed ID: 26472011
[TBL] [Abstract][Full Text] [Related]
12. Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves' disease.
Zhu W; Liu N; Zhao Y; Jia H; Cui B; Ning G
J Endocrinol Invest; 2010 Nov; 33(10):751-5. PubMed ID: 20332709
[TBL] [Abstract][Full Text] [Related]
13. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
14. Association studies of interleukin-8 gene in Graves' disease and Graves' ophthalmopathy.
Gu LQ; Jia HY; Zhao YJ; Liu N; Wang S; Cui B; Ning G
Endocrine; 2009 Dec; 36(3):452-6. PubMed ID: 19816813
[TBL] [Abstract][Full Text] [Related]
15. TH17/IL23 cytokine gene polymorphisms in bullous pemphigoid.
Tabatabaei-Panah PS; Moravvej H; Aghaei S; Akbari M; Rajabi S; Kia A; Ebrahimi E; Sadaf Z; Atoon A; Behravesh N; Ludwig RJ; Akbarzadeh R
Mol Genet Genomic Med; 2020 Dec; 8(12):e1519. PubMed ID: 33340282
[TBL] [Abstract][Full Text] [Related]
16. Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves' disease or Graves' ophthalmopathy.
Mukai T; Hiromatsu Y; Ichimura M; Fukutani T; Kaku H; Miyake I; Shoji S; Koda Y; Bednarczuk T
Thyroid; 2006 Mar; 16(3):243-8. PubMed ID: 16571086
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
Aydın AF; Develi-İş S; Doğru-Abbasoğlu S; Vural P; Ozderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
[TBL] [Abstract][Full Text] [Related]
19. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
[TBL] [Abstract][Full Text] [Related]
20. Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis.
Faragó B; Magyari L; Sáfrány E; Csöngei V; Járomi L; Horvatovich K; Sipeky C; Maász A; Radics J; Gyetvai A; Szekanecz Z; Czirják L; Melegh B
Ann Rheum Dis; 2008 Feb; 67(2):248-50. PubMed ID: 17606463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
